Exact Sciences
EXASNYSEUS Equity
$104.91▲ $0.00 (+0.00%)
Market closed · at close1h—
24h▲ 0.0%
7d▲ 0.0%
14d▲ 0.0%
30d▲ 0.0%
1y▲ 133.5%
🏦Market Cap
$355B
Large Cap
📈Revenue Growth (YoY)
+0.3%
Slowing
📊Gross Margin
63.8%
High
💵FCF Margin
11.2%
Healthy
⚖️P/S Ratio
9.2x
Elevated
Otter Score
52
Weak
📊
Analyst Ratings
Price
$104.91
Total
41
Raised
3
Lowered
13
Avg PT
$92.95
H / L
$135 / $46
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Mizuho | Downgraded | Outperform → Neutral | 2026-01-20 | — | — |
Evercore ISI Group | Downgraded | Outperform → In Line | 2026-01-05 | — | — |
Stifel | Downgraded | Buy → Hold | 2025-11-28 | — | — |
Canaccord Genuity | Downgraded | Buy → Hold | 2025-11-25 | $105.00 | +0.10% |
Jefferies | Downgraded | Buy → Hold | 2025-11-24 | $105.00 | +0.10% |
Benchmark | Downgraded | Buy → Hold | 2025-11-24 | — | — |
Wells Fargo | Downgraded | Overweight → Equal Weight | 2025-11-21 | $105.00 | +0.10% |
William Blair | Downgraded | Outperform → Market Perform | 2025-11-21 | — | — |
Barclays | Downgraded | Overweight → Equal Weight | 2025-11-21 | $105.00 | +0.10% |
Guggenheim | Downgraded | Buy → Neutral | 2025-11-21 | $60.00 | −42.80% |
BTIG | Downgraded | Buy → Neutral | 2025-11-20 | $85.00 | −19.00% |
Piper Sandler | Reiterated | Overweight | 2025-11-11 | $105.00 | +0.10% |
Baird | Reiterated | Outperform | 2025-11-04 | — | — |
TD Cowen | Reiterated | Buy | 2025-11-04 | — | — |
Craig-Hallum | Reiterated | Buy | 2025-09-11 | $105.00 | +0.10% |
RBC Capital | Reiterated | Sector Perform | 2025-08-07 | $46.00 | −56.20% |
UBS | Reiterated | Neutral | 2025-08-07 | — | — |
Scotiabank | Reiterated | Sector Outperform | 2025-02-24 | $70.00 | −33.30% |
B of A Securities | Reiterated | Buy | 2025-02-20 | — | — |
Citigroup | Reiterated | Buy | 2024-11-06 | $80.00 | −23.70% |
Goldman Sachs | Reiterated | Buy | 2024-11-06 | $65.00 | −38.00% |
Bernstein | Reiterated | Outperform | 2024-10-30 | — | — |
Credit Suisse | Reiterated | Neutral | 2023-08-02 | — | — |
Cowen & Co. | Reiterated | Outperform | 2023-02-22 | $135.00 | +28.70% |
Raymond James | Downgraded | Outperform → Market Perform | 2023-01-18 | $80.00 | −23.70% |
SVB Leerink | Reiterated | Outperform | 2023-01-12 | — | — |
Oppenheimer | Reiterated | Outperform | 2021-07-29 | — | — |
Truist Securities | Reiterated | Buy | 2021-05-12 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2019-11-15 | $105.00 | +0.10% |
Bank of America | Reiterated | Buy | 2019-10-17 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-07-19 | — | — |
BTIG Research | Upgraded | Neutral → Buy | 2018-04-03 | — | — |
Roth Capital | Upgraded | Neutral → Buy | 2017-02-22 | — | — |
Empire Asset Management | Reiterated | Sell | 2016-02-26 | — | — |
Stephens & Co. | Downgraded | Overweight → Equal Weight | 2016-02-25 | — | — |
Lake Street | Upgraded | Hold → Buy | 2015-07-23 | — | — |
JMP Securities | Reiterated | Market Outperform | 2015-05-05 | — | — |
Wedbush | Reiterated | Neutral | 2014-10-13 | — | — |
Alere Financial | Reiterated | Buy | 2013-09-16 | — | — |
Maxim Group | Reiterated | Sell | 2012-07-18 | — | — |
Auriga | Reiterated | Buy | 2012-02-24 | — | — |
Institution
Mizuho
Downgraded · Outperform → Neutral · 2026-01-20
—
—
Evercore ISI Group
Downgraded · Outperform → In Line · 2026-01-05
—
—
Stifel
Downgraded · Buy → Hold · 2025-11-28
—
—
Canaccord Genuity
Downgraded · Buy → Hold · 2025-11-25
$105.00
+0.10%
Jefferies
Downgraded · Buy → Hold · 2025-11-24
$105.00
+0.10%
Benchmark
Downgraded · Buy → Hold · 2025-11-24
—
—
Wells Fargo
Downgraded · Overweight → Equal Weight · 2025-11-21
$105.00
+0.10%
William Blair
Downgraded · Outperform → Market Perform · 2025-11-21
—
—
Barclays
Downgraded · Overweight → Equal Weight · 2025-11-21
$105.00
+0.10%
Guggenheim
Downgraded · Buy → Neutral · 2025-11-21
$60.00
−42.80%
BTIG
Downgraded · Buy → Neutral · 2025-11-20
$85.00
−19.00%
Piper Sandler
Reiterated · Overweight · 2025-11-11
$105.00
+0.10%
Baird
Reiterated · Outperform · 2025-11-04
—
—
TD Cowen
Reiterated · Buy · 2025-11-04
—
—
Craig-Hallum
Reiterated · Buy · 2025-09-11
$105.00
+0.10%
RBC Capital
Reiterated · Sector Perform · 2025-08-07
$46.00
−56.20%
UBS
Reiterated · Neutral · 2025-08-07
—
—
Scotiabank
Reiterated · Sector Outperform · 2025-02-24
$70.00
−33.30%
B of A Securities
Reiterated · Buy · 2025-02-20
—
—
Citigroup
Reiterated · Buy · 2024-11-06
$80.00
−23.70%
Goldman Sachs
Reiterated · Buy · 2024-11-06
$65.00
−38.00%
Bernstein
Reiterated · Outperform · 2024-10-30
—
—
Credit Suisse
Reiterated · Neutral · 2023-08-02
—
—
Cowen & Co.
Reiterated · Outperform · 2023-02-22
$135.00
+28.70%
Raymond James
Downgraded · Outperform → Market Perform · 2023-01-18
$80.00
−23.70%
SVB Leerink
Reiterated · Outperform · 2023-01-12
—
—
Oppenheimer
Reiterated · Outperform · 2021-07-29
—
—
Truist Securities
Reiterated · Buy · 2021-05-12
—
—
Stifel Nicolaus
Reiterated · Buy · 2019-11-15
$105.00
+0.10%
Bank of America
Reiterated · Buy · 2019-10-17
—
—
Leerink Swann
Reiterated · Outperform · 2018-07-19
—
—
BTIG Research
Upgraded · Neutral → Buy · 2018-04-03
—
—
Roth Capital
Upgraded · Neutral → Buy · 2017-02-22
—
—
Empire Asset Management
Reiterated · Sell · 2016-02-26
—
—
Stephens & Co.
Downgraded · Overweight → Equal Weight · 2016-02-25
—
—
Lake Street
Upgraded · Hold → Buy · 2015-07-23
—
—
JMP Securities
Reiterated · Market Outperform · 2015-05-05
—
—
Wedbush
Reiterated · Neutral · 2014-10-13
—
—
Alere Financial
Reiterated · Buy · 2013-09-16
—
—
Maxim Group
Reiterated · Sell · 2012-07-18
—
—
Auriga
Reiterated · Buy · 2012-02-24
—
—
One row per institution · price target from the firm's latest published target